Previous Page  20 / 34 Next Page
Information
Show Menu
Previous Page 20 / 34 Next Page
Page Background

BRAF

mutant 2

nd

-Line mCRC

Control arm in line with previously published trials

6

5,8 5,7

4,7 4,3 4,1

5,5

10,3

0

2

4

6

8

10

12

Cetux - CT

(1)

Cetux - CT

(2)

FOLIFIRI

(3)

FOLIFIRI -

Pani (3)

Cetux - CT

(4)

Cetux - Iri

(5)

FOLFIRI FOLFIRI -

Afli

mOS

1. De Roock W et al. Lancet Oncol. 2010;11:753-62; 2. Ulivi P et al.

J Transl Med

. 2012;10:87; 3. Peeters M et al.

J Clin Oncol

. 2014; 32:5s (suppl; abstr 3557);

4. Saridaki Z et al.

PLoS One

. 2011;6:e15980; 5. Loupakis F et al.

BJC

. 2009;101:715-21

n= 24

n= 12

n= 23

n= 22

n= 8

n= 13

n= 20

n= 16

VELOUR

Tejpar, World GI 2017